Flying The Web For News.
  • Career Exam Study
    Career Exam Study
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News
+ Larger Font | - Smaller Font

Globe NewsWire News Distribution Service

TUEBINGEN, Germany, July 10, 2024 (GLOBE NEWSWIRE) -- HepaRegeniX GmbH, a clinical stage company developing a novel regenerative therapy for the treatment of acute and chronic liver diseases, today announced the closing of a Series C round led by Vesalius Biocapital IV with participation of existing investors Novo Holdings, Boehringer Ingelheim Venture Fund (BIVF), and…

Posted: 2024-07-10 07:00:00

Get Full News Story On GlobeNewsWire Press Release Service

Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.

Related News Stories From The Web And More

Related Bing News Search Results

Press Release: HepaRegeniX raises €15 million Series C round to advance clinical development of HRX-215 for liver regeneration - Newscast

Democratic Super PAC raises $150 million in 24 hours since Biden dropped out

Mon, 22 Jul 2024 11:23:00 GMT CBS News reported earlier this month that wealthy donors had held $90 million in pledges if Biden remained the nominee.

American Express Raises Full-Year Earnings Per Share Guidance

Fri, 19 Jul 2024 04:03:00 GMT The 30 million new merchant locations include approximately 14 million registered merchant locations in China from year-end 2021 through May 2024. As used in this release: Card Member spending (billed ...

Complete Solar Raises $10 Million from Chinese Energy Company

Wed, 17 Jul 2024 05:59:00 GMT For more information visit and follow us on LinkedIn. This press release may contain certain forward-looking statements within the meaning of the federal securities laws with ...

BluSmart raises $24mln in Pre-Series B funding round to power its expansion plans

Mon, 15 Jul 2024 17:00:00 GMT New Delhi: BluSmart, India and South Asia's first and largest vertically integrated EV RideHailing service and EV Charging Infrastructure network, today announced the successful completion of ...

HepaRegeniX raises €15 million Series C round to advance clinical development of HRX-215 for liver regeneration

Wed, 10 Jul 2024 01:00:00 GMT The new funds of €15 million will be used to advance the clinical ... With the new funds, HepaRegeniX will advance with its clinical plans for a Phase Ib study in the US and an international ...

Blow Us A Whistle